These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31577808)

  • 1. Computational screening of antimicrobial peptides for Acinetobacter baumannii.
    Majumder A; Biswal MR; Prakash MK
    PLoS One; 2019; 14(10):e0219693. PubMed ID: 31577808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
    Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
    Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii.
    Mant CT; Jiang Z; Gera L; Davis T; Nelson KL; Bevers S; Hodges RS
    J Med Chem; 2019 Apr; 62(7):3354-3366. PubMed ID: 30848594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.
    Barksdale SM; Hrifko EJ; Chung EM; van Hoek ML
    BMC Microbiol; 2016 Aug; 16(1):189. PubMed ID: 27542832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction and simulation studies suggest the possible molecular targets of intrinsically disordered amyloidogenic antimicrobial peptides in
    Sarkar S; Kumari A; Tiwari M; Tiwari V
    J Biomol Struct Dyn; 2024 Apr; 42(6):2747-2764. PubMed ID: 37144752
    [No Abstract]   [Full Text] [Related]  

  • 8. Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii.
    Alexander PJ; Oyama LB; Olleik H; Godoy Santos F; O'Brien S; Cookson A; Cochrane SA; Gilmore BF; Maresca M; Huws SA
    NPJ Biofilms Microbiomes; 2024 Sep; 10(1):92. PubMed ID: 39349945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
    Xiong YQ; Li L; Zhou Y; Kraus CN
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
    [No Abstract]   [Full Text] [Related]  

  • 10. A linguistic model for the rational design of antimicrobial peptides.
    Loose C; Jensen K; Rigoutsos I; Stephanopoulos G
    Nature; 2006 Oct; 443(7113):867-9. PubMed ID: 17051220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria.
    Di Bonaventura I; Baeriswyl S; Capecchi A; Gan BH; Jin X; Siriwardena TN; He R; Köhler T; Pompilio A; Di Bonaventura G; van Delden C; Javor S; Reymond JL
    Chem Commun (Camb); 2018 May; 54(40):5130-5133. PubMed ID: 29717727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens.
    Jiang Z; Mant CT; Vasil M; Hodges RS
    Chem Biol Drug Des; 2018 Jan; 91(1):75-92. PubMed ID: 28636788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
    Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
    J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineered arginine-rich α-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.
    Yang CH; Chen YC; Peng SY; Tsai AP; Lee TJ; Yen JH; Liou JW
    Sci Rep; 2018 Oct; 8(1):14602. PubMed ID: 30279591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.
    Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC
    Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Conjugated Polymers: Antibacterial Agents Effective against Drug-Resistant
    Barman S; Konai MM; Samaddar S; Haldar J
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33559-33572. PubMed ID: 31424189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Bactericidal Peptides against Multidrug-Resistant
    Hazam PK; Cheng CC; Hsieh CY; Lin WC; Hsu PH; Chen TL; Lee YT; Chen JY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.